Gauruv Bose

1.3k total citations
36 papers, 449 citations indexed

About

Gauruv Bose is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, Gauruv Bose has authored 36 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pathology and Forensic Medicine, 12 papers in Neurology and 10 papers in Oncology. Recurrent topics in Gauruv Bose's work include Multiple Sclerosis Research Studies (22 papers), Venous Thromboembolism Diagnosis and Management (8 papers) and Peripheral Neuropathies and Disorders (7 papers). Gauruv Bose is often cited by papers focused on Multiple Sclerosis Research Studies (22 papers), Venous Thromboembolism Diagnosis and Management (8 papers) and Peripheral Neuropathies and Disorders (7 papers). Gauruv Bose collaborates with scholars based in Canada, United States and Netherlands. Gauruv Bose's co-authors include Mark S. Freedman, Harold Atkins, Simon Thebault, Grégoire Le Gal, Esteban Gándara, Martin H. Prins, Marc Rodger, Petra Erkens, Ronald A. Booth and Tanuja Chitnis and has published in prestigious journals such as Blood, Neurology and Annals of Neurology.

In The Last Decade

Gauruv Bose

33 papers receiving 437 citations

Peers

Gauruv Bose

PFM

NEURO

ONCOL

CCM

Seon-Kyu Lee United States

Maria Khan Pakistan

Erik Lindgren Sweden

Marc‐Antoine Pistorius France

Mickaël Tordjman France

Nathalie Roudaut France

C. Irvine United Kingdom

G. Simonetti Italy

Dennis John Kuo United States

Omidreza Tabatabaie United States

Seon-Kyu Lee United States

Gauruv Bose

45 ×0.2

PFM

81 ×0.5

183 ×1.4

NEURO

22 ×0.3

ONCOL

56 ×0.8

CCM

Citations per year, relative to Gauruv Bose Gauruv Bose (= 1×) peers Seon-Kyu Lee

Countries citing papers authored by Gauruv Bose

Since Specialization

Citations

This map shows the geographic impact of Gauruv Bose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gauruv Bose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gauruv Bose more than expected).

Fields of papers citing papers by Gauruv Bose

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gauruv Bose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gauruv Bose. The network helps show where Gauruv Bose may publish in the future.

Co-authorship network of co-authors of Gauruv Bose

This figure shows the co-authorship network connecting the top 25 collaborators of Gauruv Bose. A scholar is included among the top collaborators of Gauruv Bose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gauruv Bose. Gauruv Bose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bose, Gauruv, et al.. (2025). Role of soluble biomarkers in treating multiple sclerosis and neuroinflammatory conditions. Neurotherapeutics. 22(4). e00588–e00588. 1 indexed citations

Bose, Gauruv, et al.. (2025). Impact of Advanced Age on In‐Hospital Outcomes Following Leadless Pacemaker Implantation. Journal of Cardiovascular Electrophysiology. 36(9). 2151–2159.

Thebault, Simon, Ronald A. Booth, Carolina Rush, et al.. (2025). The utility of serum neurofilament light chain in MOGAD: Current insights and future directions. Multiple Sclerosis and Related Disorders. 98. 106410–106410. 1 indexed citations

Thebault, Simon, Seyed‐Mohammad Fereshtehnejad, Gautier Bréville, et al.. (2024). The combination of CSF neurofilament light chain and glial fibrillary acidic protein improves the prediction of long-term confirmed disability worsening in multiple sclerosis. Scientific Reports. 14(1). 29135–29135. 5 indexed citations

Bose, Gauruv, Brian C. Healy, Shrishti Saxena, et al.. (2023). Increasing Neurofilament and Glial Fibrillary Acidic Protein After Treatment Discontinuation Predicts Multiple Sclerosis Disease Activity. Neurology Neuroimmunology & Neuroinflammation. 10(6). 11 indexed citations

Bose, Gauruv, Brian C. Healy, Shrishti Saxena, et al.. (2023). Early neurofilament light and glial fibrillary acidic protein levels improve predictive models of multiple sclerosis outcomes. Multiple Sclerosis and Related Disorders. 74. 104695–104695. 12 indexed citations

Akaishi, Tetsuya, et al.. (2023). Progression independent of relapses in aquaporin4-IgG-seropositive neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein antibody-associated disease, and multiple sclerosis. Multiple Sclerosis and Related Disorders. 80. 105093–105093. 11 indexed citations

Bose, Gauruv, Brian C. Healy, Christian Barro, et al.. (2022). Younger age at multiple sclerosis onset is associated with worse outcomes at age 50. Journal of Neurology Neurosurgery & Psychiatry. 93(10). 1112–1119. 7 indexed citations

Holroyd, Kathryn B., Brian C. Healy, Maria K. Houtchens, et al.. (2022). Humoral response to COVID-19 vaccination in MS patients on disease modifying therapy: Immune profiles and clinical outcomes. Multiple Sclerosis and Related Disorders. 67. 104079–104079. 17 indexed citations

10.

Pandiyan, P., et al.. (2021). A STOCHASTIC MODEL FOR CHRONIC KIDNEY DISEASE. Advances in Mathematics Scientific Journal. 10(10).

11.

Bose, Gauruv, Vignan Yogendrakumar, Risa Shorr, et al.. (2021). Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review. BMJ Open. 11(2). e040212–e040212. 27 indexed citations

12.

Bose, Gauruv & Mark S. Freedman. (2021). Recent advances and remaining questions of autologous hematopoietic stem cell transplantation in multiple sclerosis. Journal of the Neurological Sciences. 421. 117324–117324. 5 indexed citations

13.

Bose, Gauruv, Carolina Rush, Harold Atkins, & Mark S. Freedman. (2021). A real-world single-centre analysis of alemtuzumab and cladribine for multiple sclerosis. Multiple Sclerosis and Related Disorders. 52. 102945–102945. 23 indexed citations

14.

Thebault, Simon, Gauruv Bose, Ronald A. Booth, & Mark S. Freedman. (2021). Serum neurofilament light in MS: The first true blood-based biomarker?. Multiple Sclerosis Journal. 28(10). 1491–1497. 38 indexed citations

15.

Thebault, Simon, Hyunwoo Lee, Gauruv Bose, et al.. (2020). Neurotoxicity after hematopoietic stem cell transplant in multiple sclerosis. Annals of Clinical and Translational Neurology. 7(5). 767–775. 24 indexed citations

16.

Bose, Gauruv, Simon Thebault, Harold Atkins, & Mark S. Freedman. (2019). Does Resetting the Immune System Fix Multiple Sclerosis?. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 47(1). 1–10. 7 indexed citations

17.

Bose, Gauruv, et al.. (2019). Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review protocol. Systematic Reviews. 8(1). 99–99. 14 indexed citations

18.

Duffett, Lisa, et al.. (2014). Outcomes of patients requiring insertion of an inferior vena cava filter. Blood Coagulation & Fibrinolysis. 25(3). 266–271. 9 indexed citations

19.

Erkens, Petra, Esteban Gándara, Philip S. Wells, et al.. (2011). Does the Pulmonary Embolism Severity Index accurately identify low risk patients eligible for outpatient treatment?. Thrombosis Research. 129(6). 710–714. 39 indexed citations

20.

Erkens, Petra, Esteban Gándara, Philip Wells, et al.. (2010). Safety of outpatient treatment in acute pulmonary embolism. Journal of Thrombosis and Haemostasis. 8(11). 2412–2417. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact